Skylose Pharma Private Limited - Company Profile

It is a paper private limited company based in Rangareddy, Telangana, India, established in 2024.
2024 Rangareddy, Telangana, India Active
Last Updated:
About Skylose Pharma Private Limited

Skylose Pharma Private Limited, a active private limited company, was established on 20 May 2024 in Rangareddy, Telangana, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21000TS2024PTC185615. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Sudhakar Suddapalli (Director), Anuradha Suddapalli (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 5-9-287/49, Plot No.49, 3Rd Floor, Rajeev Gandhi Nagar, I.E., Kukatpally, Rangareddy, Telangana, 500037.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21000TS2024PTC185615

  • Registration Number

    185615

  • Incorporation Date

    20 May 2024

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 9 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Skylose Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Skylose Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Skylose Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Sudhakar Suddapalli Director 20 May 2024 Current
Anuradha Suddapalli Director 20 May 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Skylose Pharma.

Enhance accessibility to Skylose Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Skylose Pharma revenue growth over time
Skylose Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Skylose Pharma?

Unlock access to Skylose Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Skylose Pharma?

Skylose Pharma has a workforce of 0 employees as of Dec 15, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Skylose Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skylose Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Skylose Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Skylose Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Skylose Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Director Appointment

    Sudhakar Suddapalli was appointed as a Director was appointed as a Director on 20 May 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.

  • Director Appointment

    Progress on Anuradha Suddapalli was appointed as a Director was appointed as a Director on 20 May 2024 & has been associated with this company since 1 year 9 months . was documented.

  • Company Incorporation

    The activity Skylose Pharma Private Limited was registered on 20 May 2024 with Roc Hyderabad & aged 1 year 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Skylose Pharma Private Limited?

The CIN of Skylose Pharma Private Limited is U21000TS2024PTC185615.

Where is Skylose Pharma Private Limited headquartered?

Skylose Pharma Private Limited is headquartered at 5-9-287/49, Plot No.49, 3Rd Floor, Rajeev Gandhi Nagar, I.E., Kukatpally, Rangareddy, Telangana, 500037.

When was Skylose Pharma Private Limited incorporated?

Skylose Pharma Private Limited was incorporated on 20 May 2024.

Who are the current directors of Skylose Pharma Private Limited?

The current directors of Skylose Pharma Private Limited are

What is the primary industry of Skylose Pharma Private Limited?

The primary industry of Skylose Pharma Private Limited is Paper.

Is Skylose Pharma Private Limited a listed company?

Skylose Pharma Private Limited is unlisted.

What is the capital structure of Skylose Pharma Private Limited?

The authorized capital of Skylose Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available